18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer-Reference-Cited by-同舟云学术

18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer

Published:2022-11-24 Issue:1 Volume:44 Page:81-90
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Ebinç Senar,Güzel Yunus,Oruç Zeynep,Kömek Halil,Kalkan Ziya,Can Canan,Taşdemir Bekir,Urakçi Zuhat,Kaplan Muhammet Ali,Küçüköner Mehmet,Işikdoğan Abdurrahman

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.;Ferlay;Int J Cancer,2015

2. Effect of neoadjuvant chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a meta-analysis.;Liu;Gastroenterol Res Pract,2016

3. Preoperative versus postoperative chemoradiotherapy for rectal cancer.;Sauer;N Engl J Med,2004

4. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010 [published correction appears in JAMA Surg. 2015 Mar 1;150(3):277].;Bailey;JAMA Surg,2015

5. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.;Collette;J Clin Oncol,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 18F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy;Nuclear Medicine Communications;2023-07-31